Related Experiment Videos
Autosomal-recessive Charcot-Marie-Tooth diseases
Jean-Michel Vallat1, Meriem Tazir, Corinne Magdelaine
1Neurology Department, University Hospital, 2 Avenue Martin Luther King, 87042 Limoges, France. vallat@unilim.fr
Journal of Neuropathology and Experimental Neurology
|May 17, 2005
Summary
Autosomal-recessive Charcot-Marie-Tooth (CMT) disease is common in Algeria due to consanguineous marriages. Nerve biopsy analysis helps identify specific gene mutations, guiding diagnosis for demyelinating and axonal forms.
Area of Science:
- Genetics
- Neurology
- Pathology
Background:
- Consanguineous marriages in the Mediterranean basin, particularly Algeria, contribute to a high prevalence of autosomal-recessive (AR) inheritance.
- AR inheritance accounts for over 50% of Charcot-Marie-Tooth (CMT) disease cases in these regions.
- CMT is classified into demyelinating (CMT 4/AR-CMT 1) and axonal (AR-CMT 2) forms, similar to dominant types.
Purpose of the Study:
- To analyze microscopic lesions in nerve biopsies from Algerian families with AR CMT.
- To correlate specific histologic phenotypes with underlying genetic mutations.
- To guide the search for novel CMT genotypes in consanguineous populations.
Main Methods:
- Examination of nerve biopsies from patients in consanguineous Algerian families.
- Clinical and histologic phenotype analysis.
- Genetic analysis of families with recessive transmission.
Main Results:
- Identification of novel CMT genotypes, including GDAP1, MTMR2, MTMR13, KIAA1985, NDGR1, periaxin, and lamin.
- Correlation between specific microscopic lesions and implicated genes.
- Characteristic lesions identified for CMT 4 (e.g., MTMR2, MTMR13, KIAA1985, periaxin) and AR-CMT 2 (e.g., lamin).
Conclusions:
- Nerve biopsy histology is crucial for identifying the genetic basis of AR CMT.
- Specific lesions can direct genetic testing towards particular genes like MTMR2, MTMR13, KIAA1985, periaxin, and lamin.
- Further genetic discoveries are anticipated in AR CMT, highlighting the complexity of the disease.